The company provides applications that enable rapid, accurate and reproducible construction or writing of ready-to-use, high-quality synthetic DNA, mRNA and short oligonucleotides in the fields of precision medicine, biologics drug discovery, vaccines, therapeutic development and genome editing. The company develops automated DNA and mRNA synthesis benchtop instruments and kits. The company is based in Delaware.